机构:[1]Department of Clinical Laboratory, the First Affiliated Hospital ofKunming Medical University, Kunming, China昆明医科大学附属第一医院[2]Key Laboratory ofAnimal Models and Human Disease Mechanisms of ChineseAcademy of Sciences & Yunnan Province, Kunming Institute ofZoology, Kunming, Yunnan, China[3]Center for Excellence inAnimal Evolution and Genetics, Chinese Academy of Sciences,Kunming, Yunnan, China
National Key Research and Development Program of China, Stem Cell and Translational Research [2016YFA0100900]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1902216, 81772996, 81802802, 82060515, 81760384]; Yunnan Applied Basic Research Projects [2019FJ009, 202001AS070037, 2019FB106, 2019FB111 2019HB076, AMHD-2020-1]; Youth Innovation Promotion Association, CAS; Yunnan Ten Thousand Talents Plan Young & Elite Talents Project
第一作者机构:[1]Department of Clinical Laboratory, the First Affiliated Hospital ofKunming Medical University, Kunming, China
共同第一作者:
通讯作者:
通讯机构:[2]Key Laboratory ofAnimal Models and Human Disease Mechanisms of ChineseAcademy of Sciences & Yunnan Province, Kunming Institute ofZoology, Kunming, Yunnan, China[3]Center for Excellence inAnimal Evolution and Genetics, Chinese Academy of Sciences,Kunming, Yunnan, China
推荐引用方式(GB/T 7714):
Xiong Qiuxia,Jiang Liping,Liu Kun,et al.miR-133b targets NCAPH to promote beta-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer[J].SIGNAL TRANSDUCTION AND TARGETED THERAPY.2021,6(1):doi:10.1038/s41392-021-00555-x.
APA:
Xiong, Qiuxia,Jiang, Liping,Liu, Kun,Jiang, Xiulin,Liu, Baiyang...&Chen, Yongbin.(2021).miR-133b targets NCAPH to promote beta-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer.SIGNAL TRANSDUCTION AND TARGETED THERAPY,6,(1)
MLA:
Xiong, Qiuxia,et al."miR-133b targets NCAPH to promote beta-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer".SIGNAL TRANSDUCTION AND TARGETED THERAPY 6..1(2021)